Abstract:Data-driven analysis and pathway-based approaches contribute to reasonable arrangements of limited resources and laboratory tests for continuously emerging commercial chemicals, which provides opportunities to save time and effort for toxicity research. With the widespread usage of organophosphate esters (OPEs) on a global scale, the concentrations generally reached up to micromolar range in environmental media and even in organisms. However, potential adverse effects and toxicity pathways of OPEs have not been systematically assessed. Therefore, it is necessary to review the current situation, formulate the future research priorities, and characterize toxicity mechanisms via data-driven analysis. Results showed that the early toxicity studies focused on neurotoxicity, cytotoxicity, and metabolic disorders. Then the main focus shifted to the mechanisms of cardiotoxicity, endocrine disruption, hepatocytes, reproductive and developmental toxicity to vulnerable sub-populations, such as infants and embryos, affected by OPEs. In addition, several novel OPEs have been emerging, such as bis(2-ethylhexyl)-phenyl phosphate (HDEHP) and oxidation derivatives (OPAsO) generated from organophosphite antioxidants (OPAs), leading to multiple potential ecological and human health risks (neurotoxicity, hepatotoxicity, developmental toxicity, etc.). Notably, in-depth statistical analysis was promising in encapsulating toxicological information to develop adverse outcome pathways (AOPs) frameworks. Subsequently, network-centric analysis and quantitative weight-of-evidence (QWOE) approaches were utilized to construct and evaluate the putative AOPs frameworks of OPEs, showing the moderate confidences of the developed AOPs. In addition, frameworks demonstrated that several events, such as nuclear receptor activation, reactive oxygen species (ROS) production, oxidative stress, and DNA damage, were involved in multiple different adverse outcome (AO), and these AOs had certain degree of connectivity. This study brought new insights into facilitating the complement of AOP efficiently, as well as establishing toxicity pathways framework to inform risk assessment of emerging OPEs.

Adverse Outcome Pathways Guide and toxicity test applications

Application of Adverse Outcome Pathways Framework in Monitoring of Toxic Chemicals from Aquatic Environments

The adverse outcome pathway concept: a pragmatic tool in toxicology

The First Steps on AOPs' Concepts, Development, and Applications in Teratology

A toxicity pathway-oriented approach to develop adverse outcome pathway: AHR activation as a case study

Adverse outcome pathways: opportunities, limitations and open questions

Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment

Harvesting the promise of AOPs: An assessment and recommendations

Research progress in drug toxicology based on systems biology

Development of an adverse outcome pathway network for nephrotoxicity

Mapping Adverse Outcome Pathways for Kidney Injury as a Basis for the Development of Mechanism-Based Animal-Sparing Approaches to Assessment of Nephrotoxicity

Adverse Outcome Pathways Mechanistically Describing Hepatotoxicity

Potential adverse outcome pathways with hazard identification of organophosphate esters

Adverse Outcome Pathway Networks II: Network Analytics.

Adverse Outcome Pathway Network Approach to Identify Endocrine Disruptor-Induced Reproductive Toxicity

Generating Adverse Outcome Pathway (AOP) of Inorganic Arsenic-Induced Adult Male Reproductive Impairment Via Integration of Phenotypic Analysis in Comparative Toxicogenomics Database (CTD) and AOP Wiki

Crowdsourcing AOP development: Leveraging the thesis literature review to identify knowledge gaps and facilitate research translation

Technology progress of alternative to animal testing

Prediction of Zebrafish Embryonic Developmental Toxicity by Integrating Omics with Adverse Outcome Pathway.

AOP-Anchored Transcriptome Analysis Catalogue Accelerates the Discovery of Environmental Toxicants in Zebrafish

AOP Report: An Upstream Network for Reduced Androgen Signaling Leading to Altered Gene Expression of Androgen Receptor–Responsive Genes in Target Tissues